Literature DB >> 28588677

Comparative study of conventional US, contrast enhanced US and enhanced MR for the follow-up of prostatic radiofrequency ablation.

Chao Feng1, Bin Hu2, Bing Hu2, Lei Chen2, Jia Li2, Jin Huang3.   

Abstract

The aim of the present study was to evaluate and compare the effectiveness of different imaging methods during follow-up of prostatic radiofrequency ablation. Prostatic radiofrequency ablation (RFA) was performed in 20 healthy beagle dogs. Various imaging examinations were used to monitor the results of RFA, including conventional ultrasound (US), contrast enhanced ultrasound (CEUS) and enhanced magnetic resonance (MR). Imaging exams were performed at five phases: Immediately following RFA, one week later, one month later, three months later and six months later. The morphology for each imaging test and histological results were recorded and compared in each phase. Based on the actual results from autopsy, the accuracy of those imaging exams was evaluated. The canine prostate gland demonstrated typical coagulative necrosis immediately following RFA. The lesion would develop into stable cyst if no other complications occurred within the six-month follow-up. Regarding the RFA lesion volume measurement and the reflection of pathological changes, conventional US was not able to accurately measure the volume of RFA lesion and missed many more details concerning the RFA-treated area than CEUS and MR during the three months. The results from CEUS exhibited comparable accuracy to those from enhanced MR at each phase. However, there were no significant differences in the results from US, CEUS and MR at six months, which may contribute to the complete formation of lesion cyst. In the early phase, conventional US was not sufficient for evaluating the efficacy of RFA. Enhanced US and MR provided clear images and accurate information. However, CEUS has the advantage of being more economical, using more convenient equipment and faster scanning, thus identifying it as the more feasible choice. Furthermore, no notable advantages were observed among any image examinations in the long-term follow-up.

Entities:  

Keywords:  magnetic resonance imaging; prostate; radiofrequency ablation; ultrasound

Year:  2017        PMID: 28588677      PMCID: PMC5450792          DOI: 10.3892/etm.2017.4399

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

1.  Magnetic resonance thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine prostate model.

Authors:  R D Peters; E Chan; J Trachtenberg; S Jothy; L Kapusta; W Kucharczyk; R M Henkelman
Journal:  Magn Reson Med       Date:  2000-12       Impact factor: 4.668

2.  Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound.

Authors:  R S Foster; R Bihrle; N Sanghvi; F Fry; K Kopecky; J Regan; J Eble; C Hennige; L V Hennige; J P Donohue
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

3.  Transperineal radiofrequency interstitial tumor ablation (RITA) of the prostate.

Authors:  B Djavan; M Susani; S Shariat; A R Zlotta; D E Silverman; C C Schulman; M Marberger
Journal:  Tech Urol       Date:  1998-06

4.  Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time.

Authors:  Aymeric Guibal; Caroline Bertin; Sophie Egels; Eric Savier; Philippe A Grenier; Olivier Lucidarme
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

5.  MRI appearance of prostate following transrectal HIFU ablation of localized cancer.

Authors:  O Rouvière; D Lyonnet; A Raudrant; C Colin-Pangaud; J Y Chapelon; R Bouvier; J M Dubernard; A Gelet
Journal:  Eur Urol       Date:  2001-09       Impact factor: 20.096

6.  The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

Authors:  Ihab R Kamel; David A Bluemke; John Eng; Eleni Liapi; Wells Messersmith; Diane K Reyes; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2006-03       Impact factor: 3.464

7.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.

Authors:  L Solbiati; T Ierace; S N Goldberg; S Sironi; T Livraghi; R Fiocca; G Servadio; G Rizzatto; P R Mueller; A Del Maschio; G S Gazelle
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

8.  MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator.

Authors:  John D Hazle; Chris J Diederich; Marko Kangasniemi; Roger E Price; Lars E Olsson; R Jason Stafford
Journal:  J Magn Reson Imaging       Date:  2002-04       Impact factor: 4.813

9.  Contrast-enhanced ultrasonography evaluation of radiofrequency ablation of the prostate: a canine model.

Authors:  Bin Hu; Bing Hu; Lei Chen; Jia Li; Jin Huang
Journal:  J Endourol       Date:  2010-01       Impact factor: 2.942

10.  Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.

Authors:  Jin-Yu Wu; Min-Hua Chen; Wei Yang; Shu-Zhi Lin; Wei Wu; Shan-Shan Yin; Hui Zhang; Kun Yan
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

View more
  3 in total

1.  Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.

Authors:  Yu Wang; Al Christopher De Leon; Reshani Perera; Eric Abenojar; Ramamurthy Gopalakrishnan; James P Basilion; Xinning Wang; Agata A Exner
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

2.  A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance.

Authors:  Ruiqing Liu; Shaobo Duan; Huicun Cao; Guangshao Cao; Zhiyang Chang; Ye Zhang; Yaqiong Li; Yuejin Wu; Luwen Liu; Lianzhong Zhang
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

3.  MRI-guided, transrectal, intraprostatic steam application as potential focal therapeutic modality for prostatic diseases in a large animal translational model: A feasibility follow-up study.

Authors:  Adriano Wang-Leandro; Florian Willmitzer; Agnieszka Karol; Beat Porcellini; Peter Kronen; Emile M Hiltbrand; Daniel Rüfenacht; Patrick R Kircher; Henning Richter
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.